ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Medinice (ICE.WAR)
Medinice stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Warsaw Stock Exchange · Poland
PLN 53.80▲ +1.32%
Prices as of Oct 27, 2026 · PLN
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Medinice in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Medinice
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Medinice a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between PLN 49.19 and PLN 58.33; in 9 out of 10, between PLN 42.30 and PLN 67.83. Estimated annual volatility is 45%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- PLN 597M
- Market cap (USD)
- $151M
- 52-week high
- PLN 95.10
- 52-week low
- PLN 10.14
- Revenue (12 months)
- PLN 0.0M
- Operating margin
- 0.0%
- Net margin
- 0.0%
- Beta
- 1.05
What this means
ATLAS does not publish a fair value for ICE.WAR right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks ICE.WAR has traded between PLN 10.14 and PLN 95.10. Today it is 43.4% below that high and 431% above its low.
Its beta is 1.05: it moves roughly in line with the market.
About the company
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery.
Want to see everything about Medinice?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Medinice do?
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery.
What is the chance ICE.WAR goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, ICE.WAR ends the month between PLN 49.19 and PLN 58.33.
How big is Medinice and what is its P/E ratio?
Medinice's market capitalization is PLN 597M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is ICE.WAR?
ATLAS estimates annual volatility at 45%. In a typical month, half of the outcomes end between PLN 49.19 and PLN 58.33.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer